1
EXECUTION COPY
-----------------------------------------------
IFX CORPORATION
PURCHASE AGREEMENT
SERIES B CONVERTIBLE PREFERRED STOCK
-----------------------------------------------
DATED AS OF MARCH 13, 2001
2
TABLE OF CONTENTS
Page
----
1. Authorization of the Securities; Nature of Agreement............................................1
----------------------------------------------------
(a) Series B Preferred Stock...............................................................1
------------------------
(b) Nature of Agreement....................................................................2
-------------------
2. Sale and Purchase of Series B Preferred Stock...................................................2
---------------------------------------------
3. [Intentionally Omitted].........................................................................2
---------------------
4. Representations and Warranties of the Company...................................................2
---------------------------------------------
(a) Organization and Good Standing.........................................................2
------------------------------
(b) Authorization..........................................................................3
-------------
(c) Capital Stock..........................................................................3
-------------
(d) Subsidiaries...........................................................................4
------------
(e) Compliance With Material Instruments...................................................5
------------------------------------
(f) Good Title.............................................................................5
----------
(g) Litigation.............................................................................5
----------
(h) Tax Matters............................................................................6
-----------
(i) Registration Rights....................................................................6
-------------------
(j) Offering...............................................................................6
--------
(k) Insurance..............................................................................6
---------
(l) Certain Transactions...................................................................7
--------------------
(m) Contracts..............................................................................7
---------
(n) Governmental Consents..................................................................9
---------------------
(o) Officers, Employees and Labor..........................................................9
-----------------------------
(p) Compliance with Laws..................................................................11
--------------------
(q) Intellectual Property.................................................................11
---------------------
(r) Environmental Matters.................................................................12
---------------------
(s) Certain Practices.....................................................................12
-----------------
(t) Brokers...............................................................................13
-------
(u) No Undisclosed Liabilities............................................................13
--------------------------
(v) Disclosure............................................................................13
----------
(w) SEC Filings...........................................................................13
-----------
(x) Financial Statements..................................................................13
--------------------
(y) Availability and Transfer of Foreign Currency.........................................14
---------------------------------------------
(z) Absence of Changes....................................................................14
------------------
(aa) Real Property Holding Company.........................................................15
-----------------------------
(bb) Investment Company Act................................................................15
----------------------
(cc) Subchapter S..........................................................................15
------------
(dd) State Takeover Statutes...............................................................15
-----------------------
i
3
Page
----
5. Representations and Warranties of the Purchasers...............................................16
------------------------------------------------
(a) Investment Intent.....................................................................16
-----------------
(b) Sophistication........................................................................16
--------------
(c) Illiquidity...........................................................................16
-----------
(d) Accredited Investor...................................................................16
-------------------
(e) Brokers...............................................................................16
-------
(f) Investment Company Act................................................................16
----------------------
(g) Requisite Power and Authority.........................................................16
-----------------------------
(h) No Conflict...........................................................................16
-----------
6. Covenants......................................................................................17
---------
(a) Pre-Closing Actions...................................................................17
-------------------
(b) Covenants Pending Closing.............................................................17
-------------------------
(c) Stockholder Approval; Information Statement...........................................17
-------------------------------------------
(d) No Solicitation.......................................................................18
---------------
(e) Books and Records.....................................................................18
-----------------
(f) Post-Closing Covenants................................................................18
----------------------
(g) Inspection Rights.....................................................................19
-----------------
7. Conditions to Obligations of the Purchasers....................................................20
-------------------------------------------
(a) Representations and Warranties........................................................20
------------------------------
(b) Performance...........................................................................20
-----------
(c) Absence of Litigation.................................................................20
---------------------
(d) Opinion of Counsel to the Company and Subsidiaries....................................20
--------------------------------------------------
(e) Consents..............................................................................20
--------
(f) Assignment of Intellectual Property...................................................21
-----------------------------------
(g) Contemporaneous Transactions..........................................................21
----------------------------
(h) Closing Papers........................................................................22
--------------
(i) Absence of Material Adverse Effect....................................................22
----------------------------------
(j) Proceedings...........................................................................23
-----------
(k) Legends...............................................................................23
-------
(l) Private Equity Fee....................................................................23
------------------
8. Conditions to the Obligations of the Company...................................................23
--------------------------------------------
(a) Representations and Warranties........................................................23
------------------------------
(b) Performance...........................................................................23
-----------
9. Survival.......................................................................................23
--------
10. Termination....................................................................................23
-----------
11. Effect of Termination..........................................................................24
---------------------
12. Miscellaneous Provisions.......................................................................24
------------------------
ii
4
Page
----
(a) Acknowledgment........................................................................24
--------------
(b) Notices...............................................................................24
-------
(c) Severability..........................................................................25
------------
(d) Governing Law.........................................................................25
-------------
(e) Publicity.............................................................................25
---------
(f) Captions and Section Headings.........................................................26
-----------------------------
(g) Amendments and Waivers................................................................26
----------------------
(h) Successors and Assigns................................................................26
----------------------
(i) Expenses..............................................................................26
--------
(j) Entire Agreement......................................................................26
----------------
(k) Exhibits..............................................................................26
--------
(l) Further Assurances....................................................................26
------------------
(m) Condition to Effectiveness............................................................27
--------------------------
(n) Counterparts..........................................................................27
------------
(o) Attorneys' Fees.......................................................................27
---------------
(p) Disclosure Generally..................................................................27
--------------------
13. Definitions....................................................................................27
-----------
(a) Definitions...........................................................................27
-----------
(b) Other Definitional Provisions.........................................................32
-----------------------------
EXHIBITS
EXHIBIT A SCHEDULE OF PURCHASERS........................................................................A-1
EXHIBIT B CERTIFICATE OF DESIGNATION, PREFERENCES AND
RIGHTS OF SERIES B PREFERRED STOCK OF IFX
CORPORATION...................................................................................B-1
EXHIBIT C SCHEDULE OF EXCEPTIONS........................................................................C-1
EXHIBIT D FORM OF OPINION OF COMPANY COUNSEL............................................................D-1
EXHIBIT E FORM OF SECOND AMENDED AND RESTATED
STOCKHOLDERS AGREEMENT........................................................................E-1
EXHIBIT F FORM OF AMENDED AND RESTATED REGISTRATION
RIGHTS AGREEMENT..............................................................................F-1
EXHIBIT G FORM OF TUTOPIA STOCK PURCHASE AGREEMENT......................................................G-1
EXHIBIT H FORM OF PERFORMANCE-BASED OPTION PLAN.........................................................H-1
iii
5
Page
----
EXHIBIT I AMENDED AND RESTATED CERTIFICATE OF
DESIGNATION, PREFERENCES AND RIGHTS OF SERIES A
PREFERRED STOCK OF IFX CORPORATION............................................................I-1
EXHIBIT J FORM OF AMENDMENT TO THE 1998 OPTION PLAN.....................................................J-1
iv
6
IFX CORPORATION
PURCHASE AGREEMENT
This Purchase Agreement is made and entered into as of the 13th day of
March, 2001, by and among IFX Corporation, a Delaware corporation (the
"Company"), and each Person listed on the Schedule of Purchasers attached as
Exhibit A hereto (the "Schedule of Purchasers") who executes this Agreement as a
Purchaser (such Persons are referred to in this Agreement, collectively, as the
"Purchasers" and individually, as a "Purchaser") and International Technology
Investments, LC, a Nevada limited liability company ("ITI"), ▇▇▇▇▇▇▇ ▇▇▇▇▇▇,
individually ("Shalom"), ▇▇▇▇ ▇▇▇▇▇▇▇▇▇▇, individually ("Eidelstein"), and the
Casty Grantor Subtrust ("Casty") only with respect to Section 12(q) hereof.
Unless defined elsewhere herein, capitalized and other defined terms shall have
the meanings specified in Section 13.
RECITALS
The Company desires to sell to the Purchasers, and the Purchasers desire
to purchase from the Company such number of shares of the Series B Convertible
Preferred Stock set forth in Section 2 hereof for a total purchase price for all
shares of Series B Preferred Stock purchased hereunder equal to Fifteen Million
Four Hundred Sixty Three Thousand Nine Hundred Seventeen Dollars ($15,463,917).
The shares will constitute one hundred percent (100%) of all the issued and
outstanding shares of the Series B Preferred Stock of the Company as of the date
of the final closing thereof, all on the terms and conditions set forth herein.
Simultaneously with the execution and delivery of this Agreement, the
Requisite Stockholders have executed and delivered a written consent to certain
of the transactions contemplated hereby, including an increase in the authorized
shares for the Stock Option Plan, adoption of the Performance-Based Stock Plan
and the issuance of shares in accordance with the Nasdaq rules and regulations.
AGREEMENT
In consideration of the premises and the mutual covenants, agreements,
hereinafter set forth, the parties to this Agreement agree as follows:
1. Authorization of the Securities; Nature of Agreement.
(a) Series B Preferred Stock. The Company has authorized the
issuance and sale pursuant to the terms and conditions of this Agreement of
4,418,262 shares of its Preferred Stock, $1.00 par value per share, to be
designated as Series B Convertible Preferred Stock (the "Series B Preferred
Stock"), as provided herein. The shares of Series B Preferred Stock have all of
the rights, preferences, privileges and restrictions set forth in the
Certificate of Designation, Number, Powers, Preferences and Relative,
Participating, Optional and Other Rights of Series B Convertible Preferred Stock
of IFX Corporation (the "Series B Certificate"), a copy of which, in the form to
be filed with the Secretary of State of the State of Delaware, is attached as
Exhibit B hereto.
7
(b) Nature of Agreement. This Agreement insofar as it
relates to the purchase of a particular number of the Series B Preferred Stock
by any Purchaser is a separate agreement between that Purchaser and the Company.
But this Agreement insofar as it relates to the rights, duties and remedies of
the Company and the Purchasers, from and after the Closing, shall be deemed to
be one Agreement.
2. Sale and Purchase of Series B Preferred Stock. Subject to the
terms and conditions set forth in this Agreement, the Company agrees to sell to
the Purchasers, and each of the Purchasers severally and not jointly agrees to
purchase from the Company, the number of shares of Series B Preferred Stock
indicated opposite such Purchaser's name on the Schedule of Purchasers (the
"Shares") for a purchase price of Three and 50/100 Dollars ($3.50) per share
(the "Per Share Price"). The sale and purchase of the Series B Preferred Stock
shall take place at the offices of ▇▇▇▇, Scholer, Fierman, ▇▇▇▇ & Handler, LLP,
▇▇▇ ▇▇▇▇ ▇▇▇▇▇▇, ▇▇▇ ▇▇▇▇, ▇▇▇ ▇▇▇▇ ▇▇▇▇▇, at 10:00 a.m., New York City time, at
a closing (the "Closing") to occur as soon as practicable after satisfaction or
waiver of the conditions to Closing set forth in Sections 7 and 8. At the
Closing, the Company will deliver to each Purchaser the Series B Preferred Stock
to be purchased by such Purchasers in the form of a single certificate (or such
greater number of certificates representing such shares as such Purchaser may
request), each dated the date of the Closing and registered in such Purchaser's
name (or in the name of such Purchaser's nominee(s)), against delivery by such
Purchaser to the Company or its order of immediately available funds in the
amount of the purchase price for such shares of Series B Preferred Stock. If at
the Closing, the Company shall fail to tender to any Purchaser the Series B
Preferred Stock to be purchased by such Purchasers, or any of the conditions
specified in Section 7 shall not have been fulfilled to the satisfaction of such
Purchaser, such Purchaser shall, at its election, be relieved of all further
obligations under this Agreement, without thereby waiving any other rights such
Purchaser may have by reason of such failure or such nonfulfillment.
3. [Intentionally Omitted].
4. Representations and Warranties of the Company. Subject to the
exceptions set forth in the Schedule of Exceptions attached as Exhibit C hereto
(the "Schedule of Exceptions"), the Company represents and warrants to each of
the Purchasers that:
(a) Organization and Good Standing. The Company and each of
its Subsidiaries is an entity duly organized and validly existing under and by
virtue of the laws of its state or country of incorporation and is in good
standing under such laws (to the extent the concept of good standing is
recognized under the laws of such jurisdictions). The Company and each of its
Subsidiaries is qualified, licensed or domesticated as a foreign corporation in
all jurisdictions where the failure to be so qualified, licensed or domesticated
would have a Material Adverse Effect. The Company and each of its Subsidiaries
has full power and authority (corporate and other) to own, lease and operate its
properties and assets and to operate the Business as currently being operated.
(i) Except as set forth on the Schedule of
Exceptions, the minute books of the Company and each of its Subsidiaries, as
previously made available to the
2
8
Purchasers, contain accurate records of all meetings of and resolutions of, or
written consents by, its shareholders and its board of directors (or committees
thereof) since the date of its incorporation.
(b) Authorization. (i) The Company has all requisite right,
power and authority (corporate or otherwise) to execute and deliver this
Agreement and each of the other agreements and instruments referred to herein to
be entered into by the Company at or prior to a Closing (including the
Certificate) in connection with the consummation of the transactions
contemplated by this Agreement (the "Other Agreements") and to perform its
obligations and consummate all of the transactions contemplated hereunder and
thereunder, including the sale and issuance of the shares of Series B Preferred
Stock to be purchased by each Purchaser at the Closing. All corporate
proceedings have been taken and all corporate authorizations have been secured
which are necessary on the part of the Company and each of its Subsidiaries to
authorize the execution, delivery and performance of this Agreement and each of
the Other Agreements.
(ii) This Agreement has been duly executed and
delivered and constitutes, and each of the Other Agreements when executed and
delivered by the Company, will constitute, legal, valid and binding obligations
of the Company, enforceable in accordance with their respective terms, subject
to applicable bankruptcy, insolvency or other similar laws affecting the
enforceability of creditors' rights generally and court decisions with respect
thereto, and the discretion of courts in granting equitable remedies.
(iii) The shares of the Series B Preferred Stock to be
purchased by each Purchaser at the Closing have been duly authorized and, when
delivered, will be duly and validly issued and outstanding, fully paid and
nonassessable, and will be free of Encumbrances. The Common Stock of the Company
issuable upon conversion of the Series B Preferred Stock (the "Conversion
Shares") (i) has been duly authorized, (ii) has been reserved for issuance upon
conversion of the Series B Preferred Stock, and (iii) when issued, will be duly
and validly issued and outstanding, fully paid and nonassessable and will be
free of Encumbrances.
(c) Capital Stock. (i) (A) On the date hereof, the
authorized capital stock of the Company consists of (1) 50,000,000 shares of
Common Stock, par value $.02 per share (the "Common Stock"), of which 13,978,645
shares of Common Stock are issued and outstanding, and (2) 10,000,000 shares of
Preferred Stock, par value $1.00 per share (the "Preferred Stock"), of which
2,030,869 shares of Preferred Stock have been designated Series A Preferred
Stock, all of which shares of Series A Preferred Stock are issued and
outstanding ("Series A Preferred Stock"); and (B) immediately after the Closing,
the authorized capital of the Company will consist of (1) 50,000,000 shares of
Common Stock, of which 13,978,645 shares of Common Stock will be issued and
outstanding, and (2) 10,000,000 shares of Preferred Stock, of which (x)
2,030,869 shares of Preferred Stock will have been designated as Series A
Preferred Stock, all of which shares will be issued and outstanding and (y)
4,418,262 shares of Preferred Stock will have been designated Series B Preferred
Stock ("Series B Preferred Stock") all of which shares will be issued and
outstanding.
3
9
(ii) Except as set forth in the Schedule of
Exceptions, the Company has not (A) issued or granted, (B) agreed to issue or
grant, or (C) caused or permitted any of its Subsidiaries to issue or grant, any
option, warrant, right or other Convertible Security which affords any Person
the right to purchase or otherwise acquire any shares of the Common Stock, the
Series A Preferred Stock or the Series B Preferred Stock, or any other security
of the Company or any of its Subsidiaries. Neither the Company nor any of its
Subsidiaries is subject to any obligation (contingent or otherwise) to purchase
or otherwise acquire or retire any shares of its securities.
(iii) All of the issued and outstanding securities of
the Company and its Subsidiaries have been duly authorized and validly issued,
are fully paid, nonassessable and free of preemptive rights (other than those
preemptive rights set forth in the Schedule of Exceptions) and other
Encumbrances, and were issued in compliance with all Applicable Laws, including
those regulating the offer, sale or issuance of securities.
(iv) Except as set forth in the Schedule of
Exceptions, no Person has any rights of first refusal or similar rights or any
preemptive rights in connection with the issuance of the shares of Series B
Preferred Stock or Conversion Shares, or with respect to any future offer, sale
or issuance of securities by the Company, any of its Subsidiaries or any of its
stockholders, other than as provided in this Agreement or after the Closing, the
Registration Rights Agreement, the Stockholders Agreement, the Series A
Certificate or the Series B Certificate.
(v) The Schedule of Exceptions sets forth a true and
correct list of (1) to the knowledge of the Company, each of the Company's
shareholders who owns, of record or beneficially, more than 5% of the Common
Stock on a Fully Diluted Basis, indicating the number and class of shares owned
by each shareholder, and such shareholder's percentage interest in the Company
and percentage interest in the Common Stock on a Fully Diluted Basis, and (2)
each of the holders of Convertible Securities, the number and type of
Convertible Securities owned by such holder and to the knowledge of the Company,
such holder's percentage interest in the Company and percentage interest in the
Common Stock on a Fully Diluted Basis.
(vi) True and correct copies of all documents
relating to the issuance and terms of all outstanding shares of capital stock
and other equity securities of the Company and all Convertible Securities of the
Company issued after November 10, 1998 have been provided to the Purchasers.
Except as set forth in the Schedule of Exceptions, each option issued to
purchase capital stock or other equity securities of the Company granted under
the Stock Option Plan or otherwise was granted pursuant to an option agreement
in substantially the form provided to the Purchasers.
(d) Subsidiaries. (i) The name of each Subsidiary of the
Company, the jurisdiction of its incorporation and the ownership of capital
stock of its shareholders are listed in the Schedule of Exceptions. Except as
set forth on the Schedule of Exceptions, all of the issued and outstanding
shares of capital stock of each Subsidiary are 100% owned, beneficially and of
record, by the Company (other than a single share (if any) of such Subsidiary
held by a nominee
4
10
of the Company in order to comply with Applicable Law), are validly issued,
fully paid and nonassessable, and free from Encumbrances.
(ii) Except for the capital stock or other securities
of the Subsidiaries listed on the Schedule of Exceptions, the Company does not
own, directly or indirectly, beneficially or of record, or have any obligations
to purchase or otherwise acquire, any capital stock or other securities of any
Person. Except as set forth on the Schedule of Exceptions, none of the
Subsidiaries owns, directly or indirectly, beneficially or of record, or has any
obligation to acquire any capital stock or other securities of any Person.
(e) Compliance With Material Instruments. Except as set
forth on the Schedule of Exceptions, the Company and each Subsidiary is not in
violation of (i) any Applicable Law, (ii) any term of its Certificate of
Incorporation or Bylaws (or equivalent documents in its jurisdiction of
organization), or (iii) any Contract to which it is subject and which is
material to the Business (collectively, the "Material Instruments"). The
execution and delivery by the Company of this Agreement and the Other
Agreements, the performance by the Company of its obligations hereunder and
thereunder and the consummation by the Company of the transactions contemplated
hereby and thereby, including the issuance and sale of the Series B Preferred
Stock, the issuance of the Conversion Shares and the taking of any other action
contemplated by this Agreement or the Other Agreements, will not (i) result in
(A) any violation of any Applicable Law, or (B) any violation of any term of the
Company's or any of its Subsidiaries' Certificate of Incorporation or Bylaws (or
equivalent documents), or (C) any violation of or any conflict with or a default
(with or without notice, lapse of time or both) under any of the Material
Instruments, which violation, conflict or default might reasonably be expected
to materially adversely affect the ability of the Company or any of its
Subsidiaries to satisfy its obligations under this Agreement, any of the Other
Agreements or any of the Material Instruments, (ii) accelerate or constitute an
event entitling the other party to any Material Instrument to accelerate the
obligations of such Material Instrument or to increase the rate of interest
presently in effect or to entitle the other party to such Material Instrument to
any other right resulting from a change-in-control or otherwise, or (iii) result
in the creation of any Encumbrance upon any of the material properties or assets
of the Company or any of its Subsidiaries. The performance by the Company or any
of its Subsidiaries of its obligations and the enforcement of its rights under
the Material Instruments will not have a Material Adverse Effect.
(f) Good Title. Except as set forth on the Schedule of
Exceptions, the Company and each of its Subsidiaries has good title to, a valid
license to, or a valid leasehold interest in, the properties and assets used by
it, in each case free and clear of all Encumbrances, except liens for current
property taxes not yet due and payable and any immaterial workmen's,
repairmen's, warehouseman's and carriers' liens arising in the ordinary course
of business. The buildings, equipment and other tangible assets of the Company
and each of its Subsidiaries are in all material respects in good operating
condition and repair, free from any known defects and are usable in the ordinary
course of the Business; and the Company and each of its Subsidiaries owns, or
has a valid leasehold interest in or license to use, all assets necessary for
the conduct of the Business as presently conducted.
5
11
(g) Litigation. (i) Except as set forth on the Schedule of
Exceptions, there are no actions, proceedings, investigations (civil, criminal,
regulatory or otherwise), arbitrations, claims, demands or grievances
("Actions") pending against the Company or any Subsidiary (or, to the best
knowledge of the Company, any basis therefor or threat thereof).
(ii) There are no judgments unsatisfied against the
Company or any Subsidiary or consent decrees or injunctions to which the
Company, any Subsidiary or any assets of the Business are subject.
(h) Tax Matters. Except as set forth in the Schedule of
Exceptions, the Company and each of its Subsidiaries (i) has timely filed
(including extensions) all Tax returns that are required to have been filed by
it with all appropriate Governmental Authorities (and all such Tax returns are
true, complete and correct in all material respects), (ii) has timely paid all
Taxes owed by it or withheld and remitted to the appropriate Governmental
Authority all Taxes which it is obligated to withhold and remit from amounts
owing to any employee (including social security taxes), creditor, customer or
third party, and (iii) has not waived any statute of limitations with respect to
Taxes or agreed to any extension of time with respect to a Tax assessment or
deficiency. The assessment of any additional Taxes for periods for which returns
have been filed is not expected to exceed the recorded liability therefor, and
there are no material unresolved questions or claims concerning the Tax
liability of the Company or any Subsidiary. There is no pending dispute with, or
notice from, any taxing authority relating to any of the Tax returns which, if
determined adversely to the Company or any Subsidiary, would result in the
assertion by any taxing authority of any valid deficiency in a material amount
for Taxes, and to the knowledge of the Company, there is no proposed liability
for a deficiency in any Tax to be imposed upon the properties or assets of the
Company, the Business or any Subsidiary. There are no federal, state, local or
foreign Tax Encumbrances on any asset of the Company, the Business or any
Subsidiary (other than Encumbrances for Taxes not yet due and payable).
(i) Registration Rights. Except as set forth in the Schedule
of Exceptions and the Registration Rights Agreement, the Company is not a party
to any agreement or commitment which obligates the Company to register under the
Securities Act of 1933, as amended (the "Securities Act"), or any other
securities law of any jurisdiction, any of its presently outstanding securities
or any of its securities which may hereafter be issued.
(j) Offering. Subject to the accuracy of the Purchasers'
representations in Section 5 of this Agreement, the offer, issuance and sale of
the Series B Preferred Stock and the Conversion Shares constitute, and will
constitute, transactions exempt from the registration and prospectus delivery
requirements of Section 5 of the Securities Act and analogous provisions of the
Applicable Laws of all other jurisdictions, and the Company has obtained (or is
exempt from the requirement to obtain) all qualifications, permits and other
consents required by all Applicable Laws governing the offer, sale or issuance
of securities.
(k) Insurance. The Schedule of Exceptions contains a true,
complete and correct list of all insurance policies covering the Business and
the respective material assets of the Company and each Subsidiary. The Company
and each Subsidiary maintains in full force
6
12
and effect such insurance policies. Neither the Company nor any Subsidiary is in
default with respect to any provision contained in any insurance policy. Neither
the Company nor any Subsidiary has failed to give any notice under any insurance
policy in due time.
(l) Certain Transactions. Except as set forth in the
Schedule of Exceptions, neither the Company nor any of its Subsidiaries is
indebted, either directly or indirectly, to any of the officers, directors,
advisory board members or stockholders of the Company or any Subsidiary, or to
any Affiliates of the foregoing, in any amount whatsoever, other than for
payment of salary for services rendered and reasonable expenses; except as set
forth on the Schedule of Exceptions, none of said officers, directors, advisory
board members, stockholders and their respective Affiliates are indebted to the
Company or any Subsidiary or, to the knowledge of the Company, have any direct
or indirect ownership interest in, or any contractual relationship with, any
Affiliates of the Company or any Subsidiary or with any Person with which the
Company or any Subsidiary has a business relationship, or any Person which,
directly or indirectly, competes with the Company or any Subsidiary. Except as
set forth in the Schedule of Exceptions, no such officer, director, advisory
board member or stockholder, nor any of their respective Affiliates, is,
directly or indirectly, a party to or otherwise an interested party with respect
to any contract, agreement, arrangement or understanding with the Company or any
Subsidiary other than agreements for the issuance of stock options to any such
Person under the Stock Option Plan.
(m) Contracts. (i) Except as expressly contemplated by this
Agreement, or as set forth in the Schedule of Exceptions, the Company and each
of its Subsidiaries is not, and as of each of the Closings the Company and each
of its Subsidiaries will not be, a party to, or bound by, and none of their
respective assets is or will be subject to, any written or oral agreement,
contract, commitment, order, license, lease or other instrument and arrangement
of the types described below (the "Contracts"):
(A) any pension, profit sharing, stock
option, employee stock purchase or other plan providing for
deferred, incentive or other compensation to employees, any
other employee benefit plan, or any contract with any labor
union;
(B) any contract for the employment or
personal services of any officer, individual employee or other
person or entity on a full-time, part-time, consulting, advisory
or other basis providing annual compensation in excess of
$125,000 or which, in any way, restricts or limits the right of
the Company or any Subsidiary to terminate such contract at
will;
(C) any loan agreement, indenture, letter of
credit, security agreement, mortgage, pledge agreement, deed of
trust, bond, note, or other agreement relating to the borrowing
of money in excess of $125,000 or to the mortgaging, pledging,
transferring of a security interest, or otherwise placing an
Encumbrance on any material asset or material group of assets
(whether tangible or intangible) of the Company or any
Subsidiary;
7
13
(D) any guarantee of the payment or
performance of any Person in excess of $125,000; any agreement
to indemnify any Person or act as a surety for an amount in
excess of $125,000; any other agreement to be contingently or
secondarily liable for the obligations of any Person; or any
"keep well" or similar credit support arrangements;
(E) any lease or agreement under which it is
the lessee of or holds or operates any property, real or
personal, owned by any other party requiring annual payments in
excess of $125,000;
(F) any contract or agreement or group of
related agreements with the same party or any group of
affiliated parties which requires or may in the future require
an aggregate payment by or to the Company or any Subsidiary in
excess of $125,000;
(G) any contract or agreement prohibiting it
from freely engaging in any business or competing anywhere in
the world;
(H) any material licenses, licensing
arrangements and other similar contracts providing in whole or
in part for the use by a third party of, or limiting the use by
the Company or any Subsidiary of, any Intellectual Property;
(I) any brokerage or finder's agreements
relating to this Transaction;
(J) any joint venture, partnership and
similar contracts involving a sharing of profits or expenses
(including joint development and joint marketing contracts);
(K) any asset purchase agreements, stock
purchase agreements and other acquisition or divestiture
agreements, including any agreements relating to the sale, lease
or disposal of any assets of the Company or any of its
Subsidiaries for consideration in excess of $50,000 or involving
continuing indemnity or other obligations;
(L) any material sales agency, marketing or
distributorship agreements;
(M) any contracts which contain "take or
pay" provisions;
(N) [Intentionally omitted];
(O) any contracts, agreements or
arrangements regarding pre-emptive rights, rights of first
refusal, put or call rights or obligations,
8
14
anti-dilution rights or other restrictions on or with respect to
the issuance, sale or redemption of the capital stock of the
Company or any of its Subsidiaries;
(P) any contracts, agreements or
arrangements regarding the rights, obligations, restrictions on
or with respect to the voting of any of the capital stock of the
Company or any of its Subsidiaries or the registration of such
stock for offering to the public pursuant to the Securities Act;
and/or
(Q) any other contract, agreement or
commitment not the subject matter of clauses (A) through (P)
above which is or could be reasonably expected to be material to
the Company, any Subsidiary or the Business.
(ii) The Company and each of its Subsidiaries has
performed all obligations required to be performed by it to date and is not in
material default under, or in material breach of, or in receipt of any claim of
material default under or material breach of, any agreement to which it is a
party or to which any of its assets is subject; the Company has no present
expectation or intention of not fully performing, or of permitting any of its
Subsidiaries not to perform fully, all such obligations; and the Company does
not have any knowledge of any material breach or anticipated material breach by
the other parties to any contract or commitment to which it or any of its
Subsidiaries is a party or to which any of its or their assets is subject.
(iii) To the knowledge of the Company, none of the
officers of the Company or any Subsidiary is a party to any oral or written
contract which prohibits, restricts or limits his or her performance of his or
her duties or the fulfillment of his or her obligations as an employee and an
officer of the Company or any Subsidiary.
(iv) Each Contract is a legal, valid, binding and
enforceable obligation of the Company or a Subsidiary, and to the knowledge of
the Company, the other parties thereto, subject to applicable bankruptcy,
insolvency, or other similar laws affecting the enforceability of creditors'
rights generally and court decisions with respect thereto, and the discretion of
courts in granting equitable remedies. Except as set forth in the Schedule of
Exceptions, no Consent of any Person is required under any Contract as a result
of or in connection with the execution and delivery by the Company or any of its
Subsidiaries or the performance by the Company or any of its Subsidiaries of its
obligations hereunder or under any of the Other Agreements or the consummation
by the Company or any of its Subsidiaries of the transactions contemplated
hereby or thereby.
(n) Governmental Consents. No Governmental Approvals or
Consents are required to be obtained under Applicable Law or the Certificate of
Incorporation and By-Laws of the Company in connection with (i) the execution,
delivery or performance by the Company of this Agreement or any of the Other
Agreements or the consummation of any transaction contemplated hereby or
thereby, and (ii) the carrying on of the Business as it is presently carried on
and is contemplated to be carried on, except as have been obtained or
accomplished and except for immaterial Governmental Approvals or Consents,
except as set forth on the Schedule of Exceptions. All such Governmental
Approvals and Consents have been duly obtained or
9
15
accomplished and are in full force and effect and the Company and its
Subsidiaries are in compliance in all material respects with each such
Governmental Approval and Consent.
(o) Officers, Employees and Labor. (i) Except as set forth
in the Schedule of Exceptions, the Company and each of its Subsidiaries has
complied in all material respects with all Applicable Laws relating to the
employment of labor, including provisions thereof relating to wages, hours,
social welfare, equal opportunity and collective bargaining. The Company does
not have any material labor relations problems. All the employment agreements
entered into between the Company or any Subsidiary, on the one hand, and their
respective employees, on the other hand, are in full force and effect.
(ii) The Schedule of Exceptions contains a list of
all officers of the Company and each of its Subsidiaries and all other current
employees and consultants whose current annual salary or rate of compensation
(including bonuses, commissions and inventive compensation) is $125,000 or more,
together with their current job titles or relationship to the Company or its
Subsidiaries. None of the Persons referred to above, nor any other employee or
consultant of the Company and its Subsidiaries, has notified the Company or such
Subsidiary that such Person will cancel or otherwise terminate such Person's
relationship with the Company or such Subsidiary, or is being terminated by the
Company or such Subsidiary.
(iii) To the Company's knowledge, none of the officers
or employees of the Company or any of its Subsidiaries is in breach of any
covenant or agreement with any previous employer or other Person with regard to
(A) restrictions on competition with the business of such previous employer or
other Person, (B) solicitation of the employees of such previous employer or
other Persons, or (C) non-disclosure of the confidential or proprietary
information of such previous employer or other Person.
(iv) Except as set forth on the Schedule of
Exceptions, the Company and its Subsidiaries do not have any Benefit Plans. The
Company has delivered to the Purchasers true, correct and complete copies of all
documents, summary plan descriptions, insurance contracts, third party
administration contracts and all other documentation created to embody all
Benefit Plans, plus descriptions of any Benefit Plans that have not been reduced
to writing.
(v) Except as set forth on the Schedule of
Exceptions and for required contributions or benefit accruals for the current
plan year, no material liability has been or is expected to be incurred by the
Company under or pursuant to any Applicable Law relating to Benefit Plans and,
to the best knowledge of the Company, no event, transaction or condition has
occurred or exists that could result in any such liability to the Company or any
of its Subsidiaries or, following the Closing, the Company, its Subsidiaries,
the Purchasers or any such Benefit Plan.
(vi) Except as set forth on the Schedule of
Exceptions, each of the Benefit Plans listed in the Schedule of Exceptions is
and has at all times been in compliance in all material respects with all
applicable provisions of Applicable Laws.
10
16
(vii) Except as specifically set forth in the Schedule
of Exceptions, the execution and performance of the transactions contemplated by
this Agreement will not (either alone or upon the occurrence of any currently
planned additional or subsequent event) constitute an event under any Benefit
Plan or individual agreement that will or may result in any payment (whether of
severance pay or otherwise), acceleration, vesting or increase in material
benefits with respect to any employee, former employee, consultant, agent or
director of the Company or any Subsidiary.
(viii) With respect to all Benefit Plans which are
funded, or are required by Applicable Law to be funded, the present value of all
accrued benefits (vested and non-vested) of each such Benefit Plan as of the
Closing Date, will not exceed the fair market value of the assets of each such
Benefit Plan as of the Closing Date.
(p) Compliance with Laws. Except as set forth on the
Schedule of Exceptions, the Company and each of its Subsidiaries is not, in any
material respects, in violation of any Applicable Laws and has not received
notice of any such violation.
(q) Intellectual Property. Except as set forth in the
Schedule of Exceptions, the Company owns free and clear of all Encumbrances, or
possesses and is validly licensed under, all Intellectual Property material to
the operation of the Business, as conducted in the past, as presently conducted
and as contemplated to be conducted. Any such licenses are in full force and
effect. No past, current, or planned activity, service or product of the Company
or any Subsidiary infringes or conflicts with the Intellectual Property of any
third party. The Company and its Subsidiaries have taken appropriate steps and
measures to establish and preserve ownership of or right to use all Intellectual
Property material to the operation of the Business. The Company owns all rights
in and to any and all Intellectual Property used or planned to be used by the
Company or any Subsidiary, or covering or embodied in any past, current or
planned activity, service or product of the Company or any Subsidiary, which
Intellectual Property was made, developed, conceived, created or written by any
consultant retained, or any employee employed, by the Company or any Subsidiary.
To the Company's knowledge, no former or current employee, and no former or
current consultant, of the Company or any Subsidiary has any rights in any
Intellectual Property made, developed, conceived, created or written by the
aforesaid employee or consultant during the period of his retention by the
Company or the Subsidiary which can be asserted against the Company or any
Subsidiary. The Company owns, or has full and unrestricted rights to use, any
and all domain names containing the word "Unete" (including the word "Unete" in
combination with any non-military extension, including ▇▇▇▇▇.▇▇▇, ▇▇▇▇▇.▇▇▇ and
▇▇▇▇▇.▇▇▇). The domain name ▇▇▇▇▇.▇▇▇ does not and will not receive an amount of
Internet traffic intended for any website or webpage of the Company that would
have a Material Adverse Effect. Except as set forth on the Schedule of
Exceptions, neither the Company nor any Subsidiary has knowledge of any
Intellectual Property owned by the Company or any Subsidiary and material to the
operation of the Business which is the subject of any Encumbrance or other
agreement granting rights therein to any third party. Except as set forth on the
Schedule of Exceptions, neither the Company nor any Subsidiary is obligated or
under any liability whatsoever to make any payments by way of royalties, fees or
otherwise to any owner, licensor of, or other claimant to, any Intellectual
Property, with respect to the use
11
17
thereof or in connection with the conduct of the Business, or otherwise. The
Company and each of its Subsidiaries has taken reasonable steps to protect,
maintain and safeguard the Intellectual Property material to the Business,
including any Intellectual Property for which improper or unauthorized
disclosure would impair its value or validity, and has executed and has had
executed appropriate nondisclosure and confidentiality agreements and made all
appropriate filings and registrations in connection with the foregoing. Neither
the Company nor any Subsidiary has knowledge of any infringement by any third
party of any Intellectual Property of the Company or any Subsidiary. There has
been no judgment, decree, injunction, rule, or order rendered by any
Governmental Authority, and no claim made against the Company or any Subsidiary,
asserting the invalidity, abuse, misuse or unenforceability of any Intellectual
Property material to the operation of the Business, or that would limit, cancel,
or question the validity of, or the rights of the Company or any Subsidiary in,
any Intellectual Property material to the operation of the Business.
(r) Environmental Matters. (i) The Company has complied in
all material respects with all applicable Environmental Laws. There is no
pending or, to the knowledge of the Company, threatened civil or criminal
litigation, written notice of violation, formal administrative proceeding, or
investigation, inquiry or information request by any Governmental Authority,
relating to any Environmental Law involving the Company or any of its
Subsidiaries.
(ii) Neither the Company, nor to the knowledge of the
Company, any third party has released any Materials of Environmental Concern
into the environment at any parcel of real property or any facility formerly or
currently owned, leased, operated or controlled by the Company. The Company is
not aware of any releases of Materials of Environmental Concern at parcels of
real property or facilities other than those owned, leased, operated or
controlled by the Company that could reasonably be expected to have an impact on
the real property or facilities owned, leased, operated or controlled by the
Company.
(iii) Set forth in the Schedule of Exceptions is a
list of all environmental reports, investigations and audits of which the
Company is aware (whether conducted by or on behalf of the Company or a third
party, and whether done at the initiative of the Company or directed by a
Governmental Authority or other third party) issued or conducted during the five
years preceding the date hereof relating to premises currently or previously
owned, leased or operated by the Company or any of its Subsidiaries. Complete
and accurate copies of each such report, or the results of each such
investigation or audit, have been provided to the Purchasers.
(s) Certain Practices. Neither the Company nor any
Subsidiary (nor any constituent corporation of any merger of which the Company
or any Subsidiary is a surviving corporation, or other Person of which the
Company or any Subsidiary is the surviving corporation) nor any of their
respective officers, employees, directors, representatives or agents has, since
the inception of the Business by the Company or any of its Subsidiaries (or
their predecessors): (i) taken any action in furtherance of any boycott not
sanctioned by the United States; (ii) entered into any contract or agreement to
conduct any transaction with any Governmental Authority, agent, representative
or resident of, or any Person based or resident in,
12
18
any of the following countries: Angola (UNITA); Burma (Myanmar); Cuba; Iran;
Iraq; Libya; North Korea; Sudan; Syria; and the Federal Republic of Yugoslavia
(Serbia and Montenegro); or (iii) knowingly offered, promised, authorized or
made, directly or indirectly, (A) any unlawful payments under Applicable Laws,
or (B) any payments or other inducements (whether or not unlawful), to any
government official, including any official of an entity owned or controlled by
a government, political party or official thereof or any candidate for political
office, with the intent or purpose of: (1) influencing any act or decision of
such official in his official capacity; (2) inducing such official to do or omit
to do any act in violation of the lawful duty of such official; (3) receiving an
improper advantage; or (4) inducing such official to use his influence with a
Governmental Authority to affect or influence any act or decision of such
Governmental Authority; in order to assist the Company or any Subsidiary in
obtaining or retaining business for or with, or directing business to, any
person.
(t) Brokers. No finder, broker, agent, financial advisor or
other intermediary has acted on behalf of the Company or any of its Affiliates
in connection with the offering of the Series B Preferred Stock or the
negotiation or consummation of this Agreement or the Other Agreements or any of
the transactions contemplated hereby or thereby. All such negotiations or the
consummation of this Agreement or the Other Agreements or any of the
transactions contemplated hereby or thereby will not give rise to any valid
claim against the Company, any Subsidiary or any of the Purchasers for any
brokerage or finder's commission, fee or similar compensation.
(u) No Undisclosed Liabilities. Except as set forth on the
Schedule of Exceptions or in the SEC Reports, neither the Company nor any
Subsidiary has any liabilities, obligations, claims, commitments or debts of any
nature, whether known or unknown, whether due or becoming due, or asserted or
unasserted (whether fixed, accrued, absolute, contingent, secured or otherwise).
The Schedule of Exceptions sets forth a true and complete schedule of accrued
liabilities and future payments due with respect to any acquisitions by the
Company or any Subsidiary of any equity securities or assets of any Person.
(v) Disclosure. This Agreement (including the Schedules and
Exhibits hereto) does not contain any untrue statement of any material fact or
omits to state a material fact necessary in order to make the statements
contained herein or therein, in light of the circumstances under which they were
made, not misleading. To the Company's knowledge, there are no facts that,
individually or in the aggregate, would have a Material Adverse Effect that have
not been set forth in this Agreement (including the Schedule of Exceptions).
(w) SEC Filings. Since January 1, 1997, the Company has
timely filed all forms, reports and documents with the SEC required to be filed
by it pursuant to the Federal securities laws and the rules and regulations of
the SEC thereunder, all of which complied in all material respects with all
applicable requirements of the Securities Act and the Exchange Act and the rules
and regulations of the SEC thereunder. The above referenced forms, reports and
documents of the Company are sometimes collectively referred to herein as the
"SEC Reports." A true and complete list of the SEC Reports is set forth in the
Schedule of Exceptions. All documents required to be filed as exhibits to the
SEC Reports have been timely filed. None of
13
19
the SEC Reports, including without limitation any financial statements or
schedules included therein, at the time filed contained any untrue statement of
a material fact or omitted to state a material fact required to be stated
therein or necessary in order to make the statements therein, in light of the
circumstances under which they were made, not misleading.
(x) Financial Statements. The consolidated balance sheets
and the related consolidated statements of income, stockholders' equity and cash
flows (including the related notes thereto) of the Company and its Subsidiaries
included in the SEC Reports complied as to form in all material respects with
the applicable accounting requirements and published rules and regulations of
the SEC with respect thereto, have been prepared in accordance with GAAP,
applied on a basis consistent with prior periods except as otherwise noted
therein, present fairly the consolidated financial position of the Company and
its Subsidiaries as of their respective dates, and the consolidated results of
their operations and their cash flows for the periods presented therein, and
reflect all adjustments necessary for the fair presentation of results for the
periods presented except as set forth on the Schedule of Exceptions.
(y) Availability and Transfer of Foreign Currency. All
requisite foreign exchange control approvals and other authorizations, if any,
by any Governmental Authority have been validly obtained and are in full force
and effect to assure: (a) the ability of the Company and its Subsidiaries to
make any and all payments necessary to (i) each Purchaser for dividend payments
on the Common Stock and the Series B Preferred Stock, or (ii) any other party in
order to conduct the Business; (b) the ability of the Company's Subsidiaries to
make any and all payments of dividends and other distributions to the Company
and any and all other intercompany payments to or from the Company; and (c) the
availability of dollars to enable each Purchaser to convert its investment to
dollars, if necessary, if such Purchaser liquidates its investment in the Series
B Preferred Stock or the Common Stock.
(z) Absence of Changes. Except as set forth in the Schedule
of Exceptions, since June 30, 2000, neither the Company nor any Subsidiary has:
(i) suffered any Material Adverse Effect;
(ii) incurred, assumed, guaranteed or discharged any
debt, claim, commitment, obligation or liability, absolute, accrued, contingent
or otherwise, whether due or to become due (including any indebtedness for
borrowed money), in excess of $100,000, individually or in the aggregate;
(iii) mortgaged, pledged or subjected to any other
Encumbrance, any material piece of property, business or assets, tangible or
intangible;
(iv) sold, transferred, leased to others or otherwise
disposed of any of the assets of the Business, in excess of $100,000,
individually or in the aggregate, or canceled or compromised any debt, claim,
commitment, liability or obligation, or waived or released any right of
substantial value, involving an amount in excess of $100,000, individually or in
the aggregate;
14
20
(v) received any written notice of termination of
any Contract with required payments thereunder in excess of $100,000;
(vi) suffered any damage, destruction or loss
(whether or not covered by insurance) to property, in excess of $100,000,
individually or in the aggregate;
(vii) transferred or granted any rights under, or
entered into any settlement regarding the breach, misappropriation, infringement
or violation of, any Intellectual Property, or modified any existing rights with
respect thereto in a manner involving payments by or to the Business in excess
of $100,000, individually or $100,000 in the aggregate;
(viii) with respect to amounts in excess of $25,000 per
year, made any change in the rate of compensation, commission, bonus or other
direct or indirect remuneration payable, or paid or agreed or made any
enforceable oral promise to pay, conditionally or otherwise, any bonus,
incentive, retention or other compensation, retirement, welfare, fringe or
severance benefit or vacation pay, to or in respect of any employee, distributor
or agent;
(ix) made any change in its accounting, auditing or
tax methods, practices or principles;
(x) encountered any labor union organizing activity,
had any actual or threatened employee strikes, work stoppages, slowdowns or
lockouts, or had any material and adverse change in its relations with its
employees, distributors, agents, customers or suppliers;
(xi) entered into any Contract, involving an amount
per year in excess of $100,000, individually or in the aggregate, or paid or
agreed to pay any brokerage or finder's fee, or incurred any severance pay
obligations by reason of, this Agreement or any of the transactions contemplated
hereby;
(xii) made any grant of credit to any customer or
distributor on terms or in amounts materially more favorable than had been
extended to that customer or distributor in the past; or
(xiii) taken any action or omitted to take any action
that has resulted or could reasonably be expected to result in the occurrence of
any of the foregoing.
(aa) Real Property Holding Company. The Company is not a real
property holding company within the meaning of Section 897(c)(2) of the United
States Internal Revenue Code of 1986, as amended.
(bb) Investment Company Act. The Company is not, nor is it
directly or indirectly controlled by or acting on behalf of, any Person that is
an "investment company" within the meaning of the United States Investment
Company Act of 1940, as amended.
15
21
(cc) Subchapter S. The Company has not elected to be treated
as a Subchapter S corporation or a collapsible corporation pursuant to Section
1362(a) or Section 341(f) of the United States Internal Revenue Code of 1986, as
amended.
(dd) State Takeover Statutes. The Board of Directors of the
Company has approved this Agreement, the Other Agreements and the transactions
contemplated hereby and thereby and the provisions of any "fair price,"
"moratorium," "control share," "interested stockholders," "affiliated
transaction" or other anti-takeover statute or regulation, and any antitakeover
or other restrictive provisions of the Company's Certificate of Incorporation
are not applicable to the transactions contemplated by this Agreement or the
Other Agreements.
5. Representations and Warranties of the Purchasers. Each Purchaser
severally (and not jointly) represents and warrants to the Company that:
(a) Investment Intent. The shares of Series B Preferred
Stock to be purchased by and issued to the Purchaser pursuant to this Agreement
are being acquired by the Purchaser solely for its own account, for investment
purposes only, and with no present intention of distributing, selling or
otherwise disposing of them.
(b) Sophistication. Such Purchaser is able to bear the
economic risk of an investment in shares of the Series B Preferred Stock to be
purchased by it pursuant to this Agreement and can afford to sustain a total
loss of such investment, and has such knowledge and experience in financial and
business matters that it is capable of evaluating the merits and risks of the
proposed investment and therefore has the capacity to protect its own interests
in connection with the purchase of its respective shares of Series B Preferred
Stock.
(c) Illiquidity. Such Purchaser understands that there is no
public market for the shares of Series B Preferred Stock to be purchased by it
and that there may never be a public market for such stock, and that even if a
market develops for such stock such Purchaser may have to bear the risk of its
investment in such stock for a substantial period of time.
(d) Accredited Investor. Such Purchaser is an "accredited
investor" within the meaning of Regulation D promulgated under the Securities
Act. In addition (but without limiting the effect of the Company's
representations and warranties contained herein), such Purchaser has received
such information as it considers necessary or appropriate for deciding whether
to purchase its respective shares of Series B Preferred Stock.
(e) Brokers. No finder, broker, agent, financial advisor or
other intermediary has acted on behalf of such Purchaser in connection with the
transactions contemplated by this Agreement or the Other Agreements.
(f) Investment Company Act. No Purchaser is an "investment
company" within the meaning of the United States Investment Company Act of 1940,
as amended.
16
22
(g) Requisite Power and Authority. Each Purchaser has all
necessary power and authority to execute and deliver this Agreement and the
Other Agreements to which it is a party and to carry out their provisions. This
Agreement has been duly executed and delivered by each Purchaser, and each of
the Other Agreements when executed and delivered by each Purchaser who is a
party thereto, will constitute the legal, valid and binding obligations of such
Purchaser, enforceable in accordance with their terms, subject to applicable
bankruptcy, insolvency, or other similar laws affecting the enforceability of
creditors' rights generally and court decisions with respect thereto, and the
discretion of courts in granting equitable remedies.
(h) No Conflict. The execution and delivery by each
Purchaser of this Agreement and the consummation of the transactions
contemplated hereby by each Purchaser will not result in any violation of or
default under, any provision of the organizational documents of such Purchaser,
any contract to which such Purchaser is a party or any applicable law, rule or
regulation, which violation or default could reasonably be expected to (i)
affect the validity of this Agreement or any agreement entered into pursuant
hereto, (ii) affect in any material respect any action taken or to be taken by
such Purchaser pursuant to this Agreement or any agreement entered into pursuant
hereto or (iii) have a material adverse effect on the properties, assets,
business or operations of such Purchaser.
6. Covenants.
(a) Pre-Closing Actions. As promptly as practicable, each
of the parties to this Agreement will (i) use commercially reasonable efforts to
take all actions required of such party to do all other things reasonably
necessary, proper or advisable to consummate the transactions contemplated
hereby by the date of the respective Closing, (ii) file or supply, or cause to
be filed or supplied, all applications, notifications and information required
to be filed or supplied by such party pursuant to Applicable Law in connection
with this Agreement, the issuance of the shares of Series B Preferred Stock
pursuant hereto and the consummation of the other transactions contemplated
hereby and by the Other Agreements; (iii) use all reasonable efforts to obtain,
or cause to be obtained, all Consents (including all Governmental Approvals and
any Consents required under any contract) necessary to be obtained by such party
in order to consummate the transactions contemplated pursuant to this Agreement
and the Other Agreements; and (iv) coordinate and cooperate with the other
parties in exchanging such information and supplying such assistance as may be
reasonably requested by the other parties in connection with any filings and
other actions to be made or taken in order to consummate the transactions
contemplated pursuant to this Agreement and by the Other Agreements.
(b) Covenants Pending Closing. Pending the Closing, neither
the Company nor any Subsidiary will, without the Purchasers' prior written
consent, take any action which would result in any of the representations or
warranties made by the Company in this Agreement not being true in any material
respect at and as of the time immediately after such action, or in any of the
covenants contained in this Agreement becoming incapable of performance. The
Company will promptly notify the Purchasers of any action or event of which it
becomes aware which has the effect of making incorrect any of such
representations or warranties in any material respect or which has the effect of
rendering any of such covenants incapable of performance.
17
23
The giving of such notice shall not relieve the Company of any liability or the
failure of any condition to the obligations of the Purchasers hereunder.
(c) Stockholder Approval; Information Statement.
(i) As promptly as possible after the execution and
delivery of this Agreement, the Company (i) will prepare and file with the SEC,
use its reasonable best efforts to have cleared by the SEC and will thereafter
mail to its stockholders as promptly as practicable an information statement
meeting the requirements of Regulation 14C promulgated under the Securities
Exchange Act of 1934, as amended (the "Information Statement"); and (ii) will
otherwise comply with Applicable Law in connection with obtaining the approval
of the Company's stockholders in connection with the transactions contemplated
hereby. The Company will provide the Purchasers with a copy of the preliminary
Information Statement and all modifications thereto prior to filing or delivery
to the SEC and will consult with the Purchasers in connection therewith. The
Company will notify the Purchasers promptly of any receipt of any comments from
the SEC or its staff and of any request by the SEC or its staff for amendments
or supplements to the Information Statement or for additional information and
will supply the Purchasers with copies of all correspondence between the Company
or any of its representatives, on the one hand, and the SEC or its staff, on the
other hand, with respect to the Information Statement. If at any time after the
mailing of the Information Statement to the Company's stockholders there shall
occur any event that should be set forth in an amendment or supplement to the
Information Statement, the Company will promptly prepare and mail to its
stockholders such an amendment or supplement. The Company will not mail any
Information Statement, or any amendment or supplement thereto, to which the
Purchasers reasonably object. The Company covenants that the Information
Statement, including any amendment or supplement thereto shall not contain any
untrue statement of a material fact or omission of a material fact required to
be stated therein or necessary to make the statements therein not misleading.
(ii) UBS covenants that any information regarding UBS
furnished by it in writing to the Company, specifically for inclusion in the
Information Statement (including any amendment or supplement thereto) will not
contain any untrue statement of a material fact or omission of a material fact
required to be stated in the Information Statement or any amendment or
supplement thereto necessary to make the statements therein not misleading.
(d) No Solicitation. Except as otherwise expressly
authorized in this Agreement, from the date hereof to the Closing, the Company
and its Subsidiaries shall (and shall cause their respective employees,
directors, agent and Affiliates to) immediately suspend any existing
negotiations or discussions relating to any sale or other transfer of actual or
beneficial ownership of the Company, any shares of capital stock of the Company
or any Subsidiary, the business or any of the Company's or any Subsidiary's
assets (other than in the ordinary course of business) (collectively, a
"Transaction"), and the Company and its Subsidiaries shall not, and shall cause
their respective employees, directors, agents and Affiliates to not, (a) solicit
any proposals or offers relating to a Transaction, or (b) negotiate or discuss
with any third party concerning any proposal or offer for a Transaction.
18
24
(e) Books and Records. The Company shall, and shall cause
each Subsidiary to, maintain books and records accurately disclosing all
payments made.
(f) Post-Closing Covenants. Until the consummation of a
Qualified Public Offering, the Company will deliver to each holder of at least
60,000 shares of Series B Preferred Stock and/or Conversion Shares:
(i) as soon as available, but in any event within
ninety (90) days after the end of each fiscal year of the Company, a copy of the
audited consolidated balance sheet of the Company and its Subsidiaries as at the
end of such fiscal year and the related audited statements of consolidated
income, stockholders' equity and changes in financial position of the Company
and its Subsidiaries for such fiscal year, setting forth in each case (after the
first full fiscal year of the Company) in comparative form the figures for the
previous year which shall be prepared in accordance with GAAP applied
consistently throughout the periods reflected therein and reported on without
any qualification as to the scope of the audit by independent certified public
accountants of nationally recognized standing;
(ii) as soon as available but in any event within
thirty (30) days after the end of each calendar month of the Company such
monthly reports as are presented to management of the Company or any of its
Subsidiaries.
(iii) No later than thirty (30) days prior to the
start of each fiscal year, an annual business plan setting forth the anticipated
strategic business activities and goals of the Company and its Subsidiaries,
including an expected annual budget and operating plan (containing projections
of operating results) for the Company and its Subsidiaries.
(iv) As soon as available, but in any event within
forty-five (45) days after the end of each semi-annual fiscal period of the
Company, an update to the monthly projections contained in the annual budget,
operating plan and business plan furnished by the Company to the Purchasers
pursuant to subsection (iii) above;
(v) promptly upon receipt thereof, copies of all
final reports submitted to the Company or any of its Subsidiaries by independent
certified public accountants in connection with each annual, interim or special
audit of the books of the Company or of any of its Subsidiaries made by such
accountants, including, without limitation, any final comment letter submitted
by such accountants to management in connection with their annual audit;
(vi) promptly upon their becoming available, copies
of all financial statements, reports, notices and proxy statements sent or made
available generally by the Company to all of its security holders in their
capacity as such or by any Subsidiary of the Company to its security holders,
other than the Company, and of all regular and periodic reports and all final
registration statements and final prospectuses, if any, filed by the Company or
any of its Subsidiaries with any securities exchange or with the SEC or any
Governmental Authority succeeding to any of its functions;
19
25
(vii) as soon as available, but in any event within
thirty (30) days after the end of each month and within ten (10) days prior to
each regularly scheduled meeting of the Board of Directors of the Company, a
narrative report prepared by the President of the Company detailing the
activities, business developments, operating results and marketing efforts of
the Company and its Subsidiaries since the date of the previous such report
delivered by the Company pursuant to this subsection (vii); and
(viii) such other information reasonably requested by
such Purchaser.
(g) Inspection Rights. Until the consummation of a Qualified
Public Offering, each holder of at least 60,000 shares of Series B Preferred
Stock and/or Conversion shares shall have the right, upon reasonable notice, to
visit and inspect any of the properties of the Company or any of its
Subsidiaries, and to discuss the affairs, finances and accounts of the Company
or any of its Subsidiaries with its directors, officers and employees, all at
such reasonable times and as often as may be reasonably requested; provided,
however, that the Company shall not be obligated to provide access to any
information which it reasonably considers to be a trade secret or similar
confidential information unless the recipient of such information executes a
nondisclosure agreement in a form reasonably acceptable to the Company.
(h) Listing Application. As soon as possible as of the date
hereof the Company shall file with Nasdaq a listing application with respect to
the Conversion Shares and use its reasonable best efforts to cause such
application to become effective.
7. Conditions to Obligations of the Purchasers. The obligation of
each of the Purchasers to purchase and pay for the Series B Preferred Stock
which it has agreed to purchase at the Closing and the other obligations of each
of the Purchasers under this Agreement are subject to the fulfillment at or
prior to the Closing of the following conditions, any of which may be waived in
writing in whole or in part by such Purchaser:
(a) Representations and Warranties. On the date of the
Closing each of the representations and warranties of the Company set forth in
this Agreement that is qualified as to materiality and each of the
representations and warranties set forth in Section 4(c) shall be true and
correct in all respects and each such representation and warranty that is not so
qualified shall be true and correct in all material respects in each case on the
date hereof and at and as of the date of the Closing with the same effect as
though such representations and warranties had been made at and as of the date
of the Closing.
(b) Performance. The Company and each of its Subsidiaries
shall have performed and complied in all material respects with all agreements
and conditions contained herein required to be performed or complied with by it
prior to or at the Closing.
(c) Absence of Litigation. (i) The consummation of the
transactions contemplated hereby shall not have been restrained, enjoined or
otherwise prohibited by any Applicable Law, including any order, injunction,
decree or judgment of any court or other
20
26
Governmental Authority; (ii) no court or other Governmental Authority shall have
determined that any Applicable Law makes illegal the consummation of the
transactions contemplated hereby and no Action with respect to the application
of any such Applicable Law to such effect shall be pending or threatened; and
(iii) no Action shall be pending or shall have been threatened which seeks to
impose liability upon any of the Purchasers by reason of the consummation of the
transactions contemplated by this Agreement.
(d) Opinion of Counsel to the Company and Subsidiaries. The
Purchasers shall each have received the written opinion of counsel for the
Company, in form and substance satisfactory to the Purchasers dated and
delivered as of the date of the Closing, substantially identical in form and
substance to Exhibit D hereto.
(e) Consents. The Company shall have obtained any and all
Consents and Governmental Approvals set forth in the Schedule of Exceptions, and
shall have made any and all filings and declarations necessary or appropriate
(A) for the consummation of the transactions contemplated by this Agreement and
the Other Agreements, (B) pursuant to Applicable Law, and (C) pursuant to
Contracts applicable to the Company in connection with the transactions
contemplated by this Agreement and the Other Agreements.
(f) Assignment of Intellectual Property. All the
Intellectual Property set forth in the Schedule of Exceptions shall have been
assigned or licensed, as applicable, to the Company pursuant to instruments in
form and substance satisfactory to the Purchasers, and the written Consent of
any third party necessary for any such assignment or license shall have been
obtained.
(g) Contemporaneous Transactions. Prior to or
contemporaneously with the Closing:
(i) Each of the Stockholders Agreement and
Registration Rights Agreement shall have been executed and delivered by each
party named on the signature pages thereof;
(ii) (A) The Company shall have sold to each
Purchaser, and each of the Purchasers shall have purchased, the shares of Series
B Preferred Stock to be purchased at the Closing by such Purchaser under this
Agreement, and (B) the Company shall have delivered to each Purchaser
certificates representing such shares of Series B Preferred Stock, each
registered in the name of such Purchaser or the name of its nominee(s).
(iii) The Series B Certificate shall have been duly
filed with the Secretary of State of the State of Delaware. The Series B
Certificate shall be in full force and effect as of the Closing and shall not
have been amended or modified.
(iv) The Series A Certificate shall have been duly
filed with the Secretary of State of the State of Delaware. The Series A
Certificate shall be in full force and effect as of the Closing and shall not
have been amended or modified.
21
27
(v) The transactions contemplated by the Tutopia
Stock Purchase Agreement attached hereto as Exhibit G shall have been
consummated at or prior to the Closing.
(vi) The Company shall have duly adopted the
Amendment to the 1998 Option Plan in accordance with Applicable Law and Nasdaq
rules and regulations.
(vii) The Company shall have duly adopted the
Performance-Based Stock Option Plan in accordance with Applicable Law and Nasdaq
rules and regulations.
(viii) The Company shall have obtained the approval of
its stockholder in accordance with Applicable Law and Nasdaq rules and
regulations necessary to consummate the transactions contemplated hereby.
(ix) The composition of the Board shall be in
compliance with the terms of the Stockholders Agreement, including the
appointment of an additional UBS designee such that UBS designees shall
constitute three out of the seven members of the Board.
(x) A Nasdaq listing application with respect to the
Conversion Shares shall have been filed and become effective.
(xi) The Stockholder Notification Period shall have
elapsed.
(xii) The requirements of the ▇▇▇▇-▇▇▇▇▇-▇▇▇▇▇▇
Antitrust Improvements Act of 1976, as amended, or any foreign anti-competition,
antitrust or pre-merger notification rules and regulations, if applicable, shall
have been complied with.
(xiii) The Company shall have received waivers from its
senior management, optionholders and the other parties to the Material
Instruments, in form and substance satisfactory to the Purchasers, of the
change-in-control provisions contained in their respective employment
agreements, option agreements and/or Material Instruments with respect to the
transactions contemplated hereby.
(h) Closing Papers. The Company shall have delivered to each
of the Purchasers all of the following:
(i) a certificate signed by the President and Chief
Executive Officer of the Company, dated as of the date of the Closing, stating
that (A) the person signing such certificate has made or has caused to be made
such investigations as are necessary to permit him to certify the accuracy of
the information set forth therein, (B) such certificate does not misstate any
material fact and does not omit to state any fact necessary to make the
certificate not misleading, and (C) the other conditions specified in this
Section 7 have been satisfied;
(ii) copies (certified by the President, Secretary or
Assistant Secretary of the Company or, if required under Applicable Law, the
applicable Governmental Authority) of
22
28
the resolutions duly adopted by the Board of Directors and Stockholders of the
Company authorizing the adoption of the Series A Certificate, Series B
Certificate and authorizing the execution, delivery and performance of this
Agreement, the Other Agreements and all other agreements referred to in this
Agreement as being executed at or prior to the Closing;
(iii) copies (certified by the Secretary or Assistant
Secretary of the Company) of the Certificate of Incorporation and Bylaws (or
equivalent documents) of the Company and, each of the Subsidiaries listed on
Schedule 7(h)(iii) hereto, in each case as amended through the date of the
Closing; and
(iv) such other documents relating to the
transactions contemplated by this Agreement as any Purchaser may reasonably
request.
(i) Absence of Material Adverse Effect. No event or series
of events shall have occurred which has had or could reasonably be expected to
have a Material Adverse Effect.
(j) Proceedings. All corporate and other proceedings of the
Company taken or to be taken in connection with the transactions contemplated
hereby and by the Other Agreements to be consummated at the Closing and all
documents incident thereto shall be reasonably satisfactory in form and
substance to each Purchaser.
(k) Legends. Each stock certificate issued by the Company to
stockholders party to the Stockholder Agreement or Registration Rights Agreement
on or prior to the date of the Closing shall have been stamped or otherwise
imprinted with a legend in substantially the form provided in Section 5.12 of
the Stockholders Agreement and Section 2 of the Registration Rights Agreement.
(l) Private Equity Fee. At the time of the Closing, the
Company shall have paid UBS, a private equity fee of 3% of the purchase price of
the Shares purchased at the Closing.
8. Conditions to the Obligations of the Company. The obligations of
the Company under this Agreement are subject to the fulfillment on or prior to
the date of the Closing of the following conditions, any of which may be waived
in writing, in whole or in part, by the Company:
(a) Representations and Warranties. On the date of the
Closing, each of the representations and warranties of the Purchasers set forth
in this Agreement shall be true and correct in all respects on the date hereof
and at and as of the date of the Closing with the same effect as though such
representations and warranties had been made at and as of the date of the
Closing.
(b) Performance. The Purchasers shall have performed and
complied in all material respects with all agreements and conditions contained
herein required to be performed by or complied with by them prior to the
Closing.
23
29
(c) Absence of Litigation. (i) The consummation of the
transactions contemplated hereby shall not have been restrained, enjoined or
otherwise prohibited by any Applicable Law, including any order, injunction,
decree or judgment of any court or other Governmental Authority; (ii) no court
or other Governmental Authority shall have determined that any Applicable Law
makes illegal the consummation of the transactions contemplated hereby and no
Action with respect to the application of any such Applicable Law to such
effect shall be pending or threatened; and (iii) no Action shall be pending or
shall have been threatened which seeks to impose liability upon any Company by
reason of the consummation of the transactions contemplated by this Agreement.
(d) Stockholder Notification. The Stockholder Notification
Period shall have elapsed.
(e) The requirements of the ▇▇▇▇-▇▇▇▇▇-▇▇▇▇▇▇ Antitrust
Improvements Act of 1976, as amended, or any foreign anti-competition,
antitrust or pre-merger notification rules and regulations, if applicable,
shall have been complied with.
9. Survival. The representations and warranties of the Company set
forth in Sections 4(a), 4(b), 4(c), 4(d), 4(e), 4(h), 4(j), 4(o), 4(q), 4(t),
4(u) and 4(y) and shall survive the Closing indefinitely. All other
representations and warranties of the Company contained herein shall expire at
the second anniversary of the Closing. The representations and warranties of the
Purchasers contained herein shall survive the Closing for a period of two years.
All covenants and agreements contained herein shall survive the Closing
indefinitely.
10. Termination. This Agreement may be terminated:
(a) by mutual written consent of all of the parties hereto;
or
(b) by any of the Purchasers by written notice to the
Company if any of the conditions to the Closing set forth in Section 7 shall not
have been fulfilled by 5:00 p.m. New York time on the date which is 60 days from
the date hereof, unless such failure shall be due to the failure of such
Purchaser to perform or comply with any of the covenants, agreements or
conditions hereof to be performed or complied with by it prior to the Closing.
11. Effect of Termination. If this Agreement is terminated pursuant
to the provisions of Section 10, then this Agreement shall become void and have
no effect, without any liability to any person in respect hereof or of the
transactions contemplated hereby on the part of any party hereto, or any of its
directors, officers, employees, consultants, agents, representatives, advisers,
stockholders or Affiliates except for any liability resulting from such party's
breach or default under this Agreement.
12. Miscellaneous Provisions.
(a) Acknowledgment. Each Purchaser acknowledges and agrees
that it has, independently and without reliance upon any other Purchaser, made
its own evaluation and decision to purchase the Series B Preferred Stock to be
purchased by it pursuant to this Agreement. Each Purchaser further acknowledges
that no other Purchaser has acted as an agent for such Purchaser or the Company
in connection with the purchase of the shares of Series B Preferred Stock
hereunder and will not be acting as an agent for such Purchaser in connection
with monitoring its investment hereunder.
(b) Notices. All notices, requests, demands, approvals,
consents, waivers or other communications required or permitted to be given
hereunder (each, a "Notice") shall be in writing and shall be (a) personally
delivered, (b) transmitted by telecopy facsimile, provided that the original
copy thereof also is sent by pre-paid, first class, registered or certified mail
(return receipt requested) or by next-day or overnight mail (to any United
States address), or by an internationally recognized express delivery service
(to any foreign address), (c) sent by first class, registered or certified mail
(return receipt requested) or by next-day or overnight mail (to any
24
30
United States address), postage and charges prepaid, or (d) delivered by an
internationally recognized express delivery service (to any foreign address),
postage and charges prepaid:
(i) if to any Purchaser, at the address and numbers
set forth at the end of this Agreement, marked for attention as therein
indicated;
(ii) if to the Company, to:
IFX Corporation
▇▇▇ ▇▇▇▇▇▇ ▇▇▇▇▇▇▇▇▇
▇▇▇▇▇ ▇▇▇
▇▇▇▇▇▇▇▇▇▇, ▇▇▇▇▇▇▇▇ ▇▇▇▇▇
Attention: Chief Executive Officer
Telephone Number: ▇▇▇-▇▇▇-▇▇▇▇
Telecopy Number: ▇▇▇-▇▇▇-▇▇▇▇
With a copy to:
▇▇▇▇, ▇▇▇▇▇▇ & ▇▇▇▇▇▇▇▇▇
▇▇▇ ▇▇▇▇▇ ▇▇▇▇▇▇▇ ▇▇▇▇▇▇
▇▇▇▇▇▇▇, ▇▇▇▇▇▇▇▇ ▇▇▇▇▇
Attention: ▇▇▇▇▇ ▇. ▇▇▇▇▇, Esq.
Telephone Number: ▇▇▇-▇▇▇-▇▇▇▇
Telecopy Number: ▇▇▇-▇▇▇-▇▇▇▇
or, in each case, at such other address and numbers as may have been furnished
in a Notice by such Person to the other parties. Any Notice shall be deemed
effective or given upon receipt (or refusal of receipt).
(c) Severability. Should any Section or any part of a
Section within this Agreement be rendered void, invalid or unenforceable by any
court of law for any reason, such invalidity or unenforceability shall not void
or render invalid or unenforceable any other Section or part of a Section in
this Agreement.
(d) Governing Law. This Agreement shall be governed by and
construed and enforced in accordance with the internal laws of the State of New
York without regard to the principles of conflicts of law thereof. Each party
hereto hereby irrevocably submits to the nonexclusive jurisdiction of the courts
of the State of New York and of the United States of America sitting in the City
of New York, Borough of Manhattan, for the adjudication of any dispute hereunder
or in connection herewith or with any transaction contemplated hereby or
discussed herein, and hereby irrevocably waives, and agrees not to assert in any
suit, action or proceeding, any claim that it is not personally subject to the
jurisdiction of any such court, that the venue thereof may not be appropriate,
that such suit, action or proceeding is improper or that this Agreement or any
of the documents referred to in this Agreement may not be enforced in or by said
courts, and each party hereto irrevocably agrees that all claims with respect to
such suit,
25
31
action or proceeding may be heard and determined in such a New York state or
federal court. Each party hereby irrevocably waives personal service of process
and consents to process being served in any such suit, action or proceeding by
mailing a copy thereof to such party in the manner provided in Section 12(b) and
agrees that such service shall constitute good and sufficient service of process
and notice thereof. Nothing contained herein shall be deemed to limit in any way
any right to serve process in any manner permitted by law. EACH PARTY HEREBY
IRREVOCABLY WAIVES ANY RIGHT IT MAY HAVE, AND AGREES NOT TO REQUEST, A JURY
TRIAL FOR THE ADJUDICATION OF ANY DISPUTE HEREUNDER OR IN CONNECTION HEREWITH OR
ARISING OUT OF THIS AGREEMENT OR ANY TRANSACTION CONTEMPLATED HEREBY.
(e) Publicity. Except as required by Applicable Law or the
requirements of any securities exchange or market (in which case the nature of
the announcement shall be described to the other parties (and the other parties
shall be allowed reasonable time to comment) prior to dissemination to the
public), no party shall make any public announcement in respect of this
Agreement or the transactions contemplated hereby without the prior written
consent of the other parties.
(f) Captions and Section Headings. Captions or section
headings contained in this Agreement are inserted as a matter of convenience and
for reference purposes only, and in no way define, limit, extend or describe the
scope of this Agreement or the intent of any provision hereof.
(g) Amendments and Waivers. Neither this Agreement nor any
term hereof, may be changed, waived, discharged or terminated orally or in
writing, except that any term of this Agreement may be amended and the
observance of any such term may be waived (either generally or in a particular
instance and either retroactively or prospectively) with (but only with) the
prior written consent of the Company and all the Purchasers; provided, however,
that no such amendment or waiver shall extend to or affect any obligation not
expressly waived or impair any right consequent therein.
(h) Successors and Assigns. All rights, covenants and
agreements of the parties contained in this Agreement shall, except as otherwise
provided herein, be binding upon and inure to the benefit of their respective
successors and assigns. This Agreement may not be assigned (by operation of law,
contract or otherwise) by any party hereto; provided, however, that each
Purchaser may assign or otherwise transfer its rights and obligations hereunder
to: (i) any Person who acquires shares of Series B Preferred Stock from any
Purchaser or any successor or assign of any Purchaser; or (ii) any
successor-in-interest to substantially all of such Purchaser's or successor's or
assign's business (whether by stock sale, asset sale or otherwise).
(i) Expenses. The Company agrees to pay the reasonable fees
and reimburse the reasonable out-of-pocket expenses, including legal and
accounting fees and expenses, of the Purchasers, upon receipt of the ▇▇▇▇
therefor, in connection with the transactions contemplated by this Agreement and
the Other Agreements; provided, however, that the Company shall not be obligated
to reimburse the Purchasers for legal fees which exceed $45,000. The Company
agrees
26
32
to reimburse reasonable travel and lodging expenses of the Purchasers in
connection with attendance of the Purchasers' representatives at meetings of the
Board of Directors of the Company and other visits to the Company associated
with exercising or fulfilling any of its rights or obligations under this
Agreement or the Other Agreements.
(j) Entire Agreement. This Agreement (including the attached
Exhibits and Schedules) contains the entire agreement and understanding of the
parties and there are no further or other agreements or understandings, written
or oral, in effect between the parties relating to the subject matter hereof.
(k) Exhibits. The Exhibits and Schedules attached to this
Agreement hereby are incorporated into and made a part of this Agreement.
(l) Further Assurances. Each party shall cooperate and take
such actions as may be reasonably requested by another party in order to carry
out the provisions and purposes of this Agreement and the Other Agreements and
the transactions contemplated hereby and thereby.
(m) Condition to Effectiveness. This Agreement shall become
effective only upon its execution and delivery by the Company and each
Purchaser.
(n) Counterparts. This Agreement may be executed (including
by facsimile transmission) with counterpart signature pages or in one or more
counterparts, each of which shall be deemed an original but all of which
together shall constitute one and the same instrument.
(o) Attorneys' Fees. If any party initiates any legal action
arising out of or in connection with this Agreement or any of the Other
Agreements, the prevailing party in such legal action shall be entitled to
recover from the other party all reasonable attorneys' fees, expert witness fees
and expenses incurred by the prevailing party in connection therewith.
(p) Disclosure Generally. The Schedule of Exceptions shall
be arranged in sections corresponding to the Sections contained in this
Agreement, and the disclosures in any section of the Schedule of Exceptions
shall qualify only (a) the corresponding section of this Agreement, and (b)
other sections of Section 4 to the extent it is clear (notwithstanding the
absence of a specific cross-reference) from a reading of the exception that such
exception is applicable to such other sections. The inclusion of any information
in the Schedules shall not be deemed to be an admission or acknowledgment, in
and of itself, that such information is material or has or would have a Material
Adverse Effect, or is outside the ordinary course of business.
(q) Covenant of Stockholders. Each of ITI, Shalom,
Eidelstein and Casty hereby agrees to execute and deliver the Stockholders
Agreement and each of ITI and Casty will execute and deliver the Registration
Rights Agreement at the Closing.
13. Definitions.
(a) Definitions. For the purposes of this Agreement, the
following terms shall have the meanings specified below:
"Action" has the meaning set forth in Section 4(g)(i).
27
33
"Affiliate" of a specified Person means (i) any Person that
directly or indirectly, through one or more intermediaries, controls, is
controlled by, or is under common control with, such specified Person, or (ii)
in the case of a natural Person, such Person's spouse, parent or lineal
descendant (whether by blood or adoption and including stepchildren). "Control"
(including the terms "controlled by" and "under common control with") means the
possession, directly or indirectly, of the power to direct or cause the
direction of the management policies of a Person, whether through the ownership
of voting securities, by contract or credit arrangement, as trustee or executor,
or otherwise.
"Agreement" shall mean this Agreement (including the Schedules
and Exhibits hereto), as amended, supplemented or modified from time to time in
accordance with the provisions hereof.
"Applicable Law" shall mean, with respect to any Person, any and
all provisions of any constitution, treaty, statute, law, regulation, ordinance,
code, rule, judgment, rule of common law, order, decree, award, injunction,
Governmental Approval, concession, grant, franchise, license, agreement,
directive, guideline, policy, requirement, or other governmental restriction or
any similar form of decision of, or determination by, or any interpretation or
administration of any of the foregoing by, any Governmental Authority, whether
in effect as of the date hereof or thereafter and in each case as amended,
applicable to such Person or its subsidiaries or their respective assets.
"Amendment to the 1998 Option Plan" shall mean the amendment to
the 1998 IFX Corporation Stock Option and Incentive Plan in form and substance
identical to Exhibit J hereto.
"Benefit Plan" shall mean any plan, agreement or arrangement,
formal or informal, whether oral or written, whereby the Company or any
Subsidiary provides any benefit to any present or former officer, director or
employee, or dependent or beneficiary thereof, including any profit sharing,
deferred compensation, stock option performance stock, pension, death benefit or
other fringe benefit, employee stock purchase, bonus, severance, retirement,
health or insurance plan.
"Board" shall mean the Board of Directors of the Company.
"Business" shall mean the business of the Company and each of
its Subsidiaries.
"Casty" has the meaning set forth in the first paragraph
hereof.
"Closing" has the meaning set forth in Section 2.
"Common Stock" has the meaning set in Section 4(c)(i).
"Company" has the meaning set forth in the first paragraph
hereof.
"Consent" shall mean any consent, approval, authorization,
waiver, permit, grant, franchise, concession, agreement, license, exemption or
order of, registration, certificate,
28
34
declaration or filing with, or report or notice to, any Person, including any
Governmental Authority.
"Contracts" has the meaning set forth in Section 4(m)(i).
"Contracts Schedule" has the meaning set forth in Section
4(m)(i).
"Conversion Shares" has the meaning set forth in Section
4(c)(iv).
"Convertible Securities" shall mean (i) any rights, options or
warrants issued by the Company or any of its Subsidiaries to acquire Common
Stock or any capital stock of the Company or any Subsidiary, including the
shares of Series B Preferred Stock to be issued hereunder, (ii) any notes,
debentures, shares of preferred stock or other securities, options, warrants or
rights issued by the Company or any of its Subsidiaries, which are convertible
or exercisable into, or exchangeable for, Common Stock or any capital stock of
the Company or any Subsidiary and (iii) any contractual or other obligation
(whether fixed, contingent or otherwise) to issue shares of capital stock or
other securities of the Company or any Subsidiary in connection with the
acquisition of any securities, business or enterprise (including any Internet
Service Provider).
"$" or "dollars" shall mean lawful money of the United States of
America.
"▇▇▇▇▇▇▇▇▇" has the meaning set forth in the first paragraph
hereof.
"Encumbrance" shall mean any lien, encumbrance, hypothecation,
right of others, proxy, voting trust or similar arrangement, pledge, security
interest, collateral security agreement, limitations on voting rights,
limitations on rights of ownership filed with any Governmental Authority, claim,
charge, equities, mortgage, pledge, objection, title defect, title retention
agreement, option, restrictive covenant, restriction on transfer, right of first
refusal, right of first offer, statutory or contractual preemptive right or any
comparable interest or right created by or arising under Applicable Law, of any
nature whatsoever.
"Environmental Law" means any United States federal, state,
local or foreign law, statute, rule or regulation or the common law relating to
the protection of human health or the environment, including, without
limitation, CERCLA (as defined below), the United States federal Resource
Conservation and Recovery Act of 1976 as amended (the "Recovery Act"), any
statute, regulation or order pertaining to (i) treatment, storage, disposal,
generation and transportation of industrial, toxic or hazardous materials or
substances or solid or hazardous waste; (ii) air, water and noise pollution;
(iii) groundwater and soil contamination; (iv) the release or threatened release
into the environment of industrial, toxic or hazardous materials or substances,
or solid or hazardous waste, including, without limitation, emissions,
discharges, injections, spills, escapes or dumping of pollutants, contaminants,
or chemicals; (v) the protection of wild life, marine life and wetlands,
including, without limitation, all endangered and threatened species; (vi)
storage tanks, vessels, abandoned or discarded barrels, containers and other
closed receptacles; (vii) health and safety of employees and other persons; and
(viii) manufacture, processing, use, distribution, treatment, storage, disposal,
transportation or handling of pollutants, contaminants, toxic or hazardous
materials or substances or oil or petroleum
29
35
products or solid or hazardous waste. As used herein, the terms "release" and
"environment" has the meaning set forth in the United States federal
Comprehensive Environmental Response, Compensation and Liability Act of 1980, as
amended ("CERCLA").
"Fully Diluted Basis" shall mean, when used with respect to
outstanding shares of Common Stock, all shares of Common Stock which would be
outstanding after giving effect to the transactions contemplated by this
Agreement and assuming the exercise, conversion or exchange of all Convertible
Securities.
"GAAP" shall mean United States generally accepted accounting
principles consistently applied.
"Governmental Approvals" shall mean any action, order,
authorization, consent, approval, license, lease, waiver, franchise, concession,
agreement, license, ruling, permit, tariff, rate, certification, exemption of,
filing or registration by or with, or report or notice to, any Governmental
Authority.
"Governmental Authority" shall mean any nation or foreign or
domestic government, any state or other political subdivision thereof, any
entity exercising executive, legislative, judicial, regulatory or administrative
functions of or pertaining to government (including, without limitation, any
government authority, agency, department, board, commission or instrumentality
of the United States, any State of the United States or any political
subdivision thereof), or any tribunal or arbitrator(s) of competent
jurisdiction, or any self-regulatory organization.
"include", "includes", "included" and "including" shall be
construed as if followed by the phrase "without being limited to".
"Intellectual Property" shall mean any and all worldwide,
international, U.S. and/or foreign, patents, all applications therefor and all
reissues, reexaminations, continuations, continuations-in-part, divisions, and
patent term extensions thereof, inventions (whether patentable or not),
discoveries, improvements, concepts, innovations, industrial models, registered
and unregistered copyrights, copyright registrations and applications, author's
rights, works of authorship (including any text or artwork of any kind, and
software of all types in whatever medium, inclusive of computer programs, source
code, object code and executable code, and related documentation), URLs, web
sites, web pages and any part thereof, technical information, know-how, trade
secrets, drawings, designs, design protocols, specifications for parts and
devices, quality assurance and control procedures, design tools, manuals,
research data concerning historic and current research and development efforts,
including the results of successful and unsuccessful designs, databases and
proprietary data, proprietary processes, technology, engineering, discoveries,
formulae, algorithms, operational procedures, trade names, trade dress,
trademarks, domain names, and service marks, and registrations and applications
therefor, the goodwill of the business symbolized or represented by the
foregoing, customer lists and other proprietary information and common-law
rights.
"ITI" has the meaning set forth in the first paragraph hereof.
30
36
"Material Adverse Effect" shall mean any event, circumstance,
occurrence, fact, condition, change or effect that is materially adverse to (i)
the Business, operations, results of operations, financial condition, prospects,
properties, assets or liabilities of the Company and its Subsidiaries, taken as
a whole, or (ii) the ability of the Company to perform fully its obligations
hereunder and under the Other Agreements and to consummate the transactions
contemplated hereby and thereby. For the purposes of this Agreement, a currency
devaluation or foreign exchange restriction or other actions by any Governmental
Authority limiting repatriation of capital or any other material change in the
governmental or political climate of the countries in which the Company or its
Subsidiaries carry out the Business shall be deemed to have a Material Adverse
Effect.
"Material Instruments" has the meaning set forth in Section
4(e).
"Materials of Environmental Concern" means any chemicals,
pollutants or contaminants, hazardous substances (as such term is defined under
CERCLA), solid wastes and hazardous wastes (as such terms are defined under the
Recovery Act), toxic materials, oil or petroleum and petroleum products, or any
other material subject to regulation under any Environmental Law.
"Notice" has the meaning set forth in Section 12(b).
"Other Agreements" has the meaning set forth in Section 4(b)(i).
"Per Share Price" has the meaning set forth in Section 2.
"Performance-Based Stock Option Plan" shall mean the IFX
Corporation 2001 Stock Option plan to be adopted by the Company in form and
substance identical to Exhibit H hereto.
"Person" or "person" shall mean any natural person, company,
corporation, association, partnership, organization, business, firm, joint
venture, trust, unincorporated organization or any other entity or organization,
and shall include any Governmental Authority.
"Preferred Stock" has the meaning set forth in Section 4(c)(i).
"Qualified Public Offering" shall mean an underwritten public
offering of shares of Common Stock for which the Company has obtained a firm
commitment from one or more underwriter(s) for at least $60 million of Common
Stock and in which the Company receives gross proceeds from the sale of Common
Stock to the public of at least $45 million (before deduction of underwriter's
discounts and commissions), and which values the equity of the Company at no
less than $200 million pre-offering.
"Registration Rights Agreement" means the Amended and Restated
Registration Rights Agreement to be entered into among the Company and the
stockholders of the Company, in form and substance identical to Exhibit F
hereto.
31
37
"Requisite Stockholders" means UBS, Casty Grantor Subtrust, ▇▇▇
▇. ▇▇▇▇▇, ▇▇▇▇▇▇▇ ▇▇▇▇▇▇, International Technology Investments, LC and ▇▇▇▇
▇▇▇▇▇▇▇▇▇▇ and their respective Affiliates holding voting stock of the Company.
"Schedule of Exceptions" has the meaning set forth in the first
paragraph of Section 4.
"Schedule of Purchasers" has the meaning set forth in the first
paragraph hereof.
"Securities Act" has the meaning set forth in Section 4(i).
"Series A Certificate" means the Amended and Restated
Certificate of Designation, Numbers, Powers, Preferences and Relative,
Participating, Optional and Other Rights of Series A Preferred Stock in form and
substance identical to Exhibit I attached hereto.
"Series A Preferred Stock" has the meaning set forth in Section
4(c)(i).
"Series B Certificate" has the meaning set forth in Section
1(a).
"Series B Preferred Stock" has the meaning set forth in Section
1(a).
"SEC" shall mean the U.S. Securities and Exchange Commission or
any successor agency thereto.
"SEC Reports" has the meaning set forth in Section 4(w).
"Shalom" has the meaning set forth in the first paragraph
hereof.
"Shares" shall have the meaning set forth in Section 2.
"Stock Option Plan" means the IFX Corporation Directors Stock
Option Plan and the 1998 IFX Corporation Stock Option and Incentive Plan.
"Stockholder Notification Period" means the twenty (20) calendar
day period after the Information Statement is sent or given to the Company's
stockholders pursuant to Rule 14c- 2(b) promulgated under the Securities
Exchange Act of 1934, as amended.
"Stockholders Agreement" means the Amended and Restated
Stockholders Agreement to be entered into among the Company and the stockholders
of the Company, in form and substance identical to Exhibit E hereto.
"Subsidiary" means any Person of which equity securities
possessing a majority of (i) the ordinary voting power in electing the board of
directors, or (ii) the outstanding capital stock or other equity interests, are,
at the time as of which such determination is being made, owned by the Company
either directly or indirectly through one or more Subsidiaries.
32
38
"Taxes" shall mean any domestic or foreign taxes, charges, feed,
levies or other assessments, including any income, alternative, minimum,
accumulated earnings, personal holding company, franchise, capital stock, net
worth, capital, profits, windfall profits, gross receipts, value added, sales,
use, goods and services, excise, customs duties, transfer, conveyance, mortgage,
registration, stamp, documentary, recording, premium, severance, environmental,
real property, personal property, ad valorem, intangibles, rent, occupancy,
license, occupational, employment, unemployment insurance, social security,
disability, worker's compensation, payroll, health care, withholding, estimated
or other taxes, charges, fees, levies or other assessments, and including any
interest, penalties or additions relating thereto, imposed by any Governmental
Authority or other taxing authority.
"Transaction" has the meaning set forth in Section 6(d).
"UBS" shall mean (i) UBS Capital Americas III, L.P., a Delaware
limited partnership, (ii) UBS Capital LLC, a Delaware limited liability company
and (iii) any Affiliate of either of the foregoing entities, individually and
collectively.
(b) Other Definitional Provisions. The words "hereof",
"herein", and "hereunder" and words of similar import shall refer to this
Agreement as a whole and not to any particular provision of this Agreement.
Terms defined in the singular shall have a comparable meaning when used in the
plural and vice versa. Whenever a representation or warranty made by a Person
herein refers to the knowledge of such Person, such knowledge shall be deemed to
consist of the actual knowledge of such Person or the knowledge which would have
been present after reasonable due inquiry by such Person. A Person (other than
an individual) will be deemed to have "knowledge" of a particular fact or other
matter if any individual who is serving, or who has at any time served, as a
director, executive officer, member, partner, executor or trustee of such Person
(or a Person acting in any similar capacity) has, or any time had, actual
knowledge of such fact or other matter, or should have had knowledge thereof
given such individual's office or capacity and given industry standards or given
reasonable due inquiry by such individual.
33
39
IN WITNESS WHEREOF, the parties hereto have executed and delivered this
Agreement as of the date first above written.
IFX CORPORATION
By:
--------------------------------
Name:
Title:
Agreed and Accepted only as to
Section 12(q) hereof:
CASTY GRANTOR SUBTRUST
By:___________________
Name:
Title:
INTERNATIONAL TECHNOLOGY
INVESTMENTS, LC
By:____________________
Name:
Title:
_______________________
▇▇▇▇▇▇▇ ▇▇▇▇▇▇
_______________________
▇▇▇▇ ▇▇▇▇▇▇▇▇▇▇
40
Purchaser:
The undersigned hereby executes and delivers this Agreement as of the
date first above written as one of the Purchasers referred to therein for the
purpose of purchasing from the Company the applicable Shares at the Closing.
UBS CAPITAL AMERICAS III, L.P.
By: UBS Capital Americas III, LLC
By:
---------------------------------
Name:
Title:
By:
---------------------------------
Name:
Title:
Address: UBS Capital Americas III, L.P.
c/o UBS Capital Americas III, LLC
▇▇▇ ▇▇▇▇ ▇▇▇▇▇▇
▇▇▇ ▇▇▇▇, ▇▇ ▇▇▇▇▇
Attention: ▇▇▇▇▇▇▇ ▇. ▇▇▇▇▇
Telephone No.: (▇▇▇) ▇▇▇-▇▇▇▇
Telecopy No.: (▇▇▇) ▇▇▇-▇▇▇▇
With a copy
of Notices to: ▇▇▇▇, Scholer, Fierman, ▇▇▇▇ & Handler, LLP
▇▇▇ ▇▇▇▇ ▇▇▇▇▇▇
▇▇▇ ▇▇▇▇, ▇▇▇ ▇▇▇▇ ▇▇▇▇▇
Attention: ▇▇▇▇▇ ▇▇▇▇▇, Esq.
Telephone No.: (▇▇▇) ▇▇▇-▇▇▇▇
Telecopy No.: (▇▇▇) ▇▇▇-▇▇▇▇
41
Purchaser:
The undersigned hereby executes and delivers this Agreement as of the
date first above written as one of the Purchasers referred to therein for the
purpose of purchasing from the Company the applicable Shares at the Closing.
UBS CAPITAL LLC
By:
----------------------------
Name:
Title:
By:
----------------------------
Name:
Title:
Address: UBS Capital LLC
▇▇▇ ▇▇▇▇ ▇▇▇▇▇▇
▇▇▇ ▇▇▇▇, ▇▇ ▇▇▇▇▇
Attention: ▇▇▇▇▇▇▇ ▇. ▇▇▇▇▇
Telephone No.: (▇▇▇) ▇▇▇-▇▇▇▇
Telecopy No.: (▇▇▇) ▇▇▇-▇▇▇▇
With a copy
of Notices to: ▇▇▇▇, Scholer, Fierman, ▇▇▇▇ & Handler, LLP
▇▇▇ ▇▇▇▇ ▇▇▇▇▇▇
▇▇▇ ▇▇▇▇, ▇▇▇ ▇▇▇▇ ▇▇▇▇▇
Attention: ▇▇▇▇▇ ▇▇▇▇▇, Esq.
Telephone No.: (▇▇▇) ▇▇▇-▇▇▇▇
Telecopy No.: (▇▇▇) ▇▇▇-▇▇▇▇